Technical articles
15/12/2021
Discovering our -omics activities
To demystify this area of activity and offer you the opportunity to better understand it, our biostatistics and bioinformatics -om
17/11/2021
The headquarters of Efor Group is moving.
The Lyon-based teams of Efor and CVO-EUROPE are relocating to the brand new premises at Racing Park in Champagne au mont d’o
16/11/2021
Post-Market Surveillance (PMS), Post-Market Clinical Follow-up (PMCF/PMPF) and PMCF/PMPF Studies
Post-Market SurveillanceFor any MD (including IVDMDs) placed on the market, made available on the market or put into service, manu
5/09/2021
Soladis joins the Efor Group, bringing 20 years of expertise in statistics and data management
At the end of 2020, our group joined forces with CVO-EUROPE , a company with over 25 years' experience working with major pharmac
27/07/2021
Data Integrity – The adventures continues
Why data integrity?Data are central to all our interactions, communications and strategic decision-making. In the pharmaceutical a
Join our team
Consult our offers
8/01/2021
Efor and CVO Europe join forces to become the european leader in Life Sciences consulting
Efor Group continues its growth journey with the acquisition of CVO Europe
20/02/2020
Validation of analytical procedures according to the ICH guidelines
Since 1990, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has been
4/02/2020
New trends in medical journals: limited use of p-values in favour of estimated indicators and confidence intervals
Why is the p-value, once so widely used, now being called into question?
